Guardant Average Inventory from 2010 to 2026
| GH Stock | USD 93.90 4.07 4.15% |
Average Inventory | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 0.0 |
Check Guardant Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardant Health's main balance sheet or income statement drivers, such as Net Interest Income of 15.2 M, Interest Income of 18.2 M or Depreciation And Amortization of 25.2 M, as well as many indicators such as Price To Sales Ratio of 25.47, Dividend Yield of 0.0 or Days Sales Outstanding of 85.24. Guardant financial statements analysis is a perfect complement when working with Guardant Health Valuation or Volatility modules.
Guardant | Average Inventory | Build AI portfolio with Guardant Stock |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Guardant Health Correlation against competitors. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is there potential for Health Care Providers & Services market expansion? Will Guardant introduce new products? Factors like these will boost the valuation of Guardant Health. Market participants price Guardant higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.32) | Revenue Per Share | Quarterly Revenue Growth 0.394 | Return On Assets | Return On Equity |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Guardant Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.